ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Oil Prices Rise as Ukraine Peace Talks and Middle East Tensions Stir Supply Concerns 
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement 
Forex Markets Hold Steady as Traders Await Fed Minutes Amid Thin Year-End Volumes 
Bolsonaro Undergoes Second Medical Procedure for Persistent Hiccups While Hospitalized in Brasilia 
China to Cut Import Tariffs on Key Commodities and Medical Products From Next Year 
European Defense Stocks Slide as Trump Signals Progress in Ukraine-Russia Peace Talks 
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change 
Federal Reserve Begins Treasury Bill Purchases to Stabilize Reserves and Money Markets 
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 
A US Court of Appeals revived a challenge by Johnson & Johnson unit Auris Health Inc to a patent on a robotic tool used to perform surgery held by rival Intuitive Surgical Operations Inc.
The US Patent Trial and Appeal Board (PTAB) found that the two earlier patents included all the elements of Intuitive's. However, it said the patent was not obvious because a person of ordinary skill would not have been motivated to combine them because of skepticism at the time of the invention for using robotic systems during surgery in the first place.
A panel of the US Court of Appeals for the Federal Circuit Court ruled 2-1to direct the US Patent and Trademark Office's invention tribunal to revisit its determination that the 2012 patent, which covers a technique for more readily swapping out different surgical tools on a robotic surgical arm, was not obvious.
Auris petitioned the PTAB to invalidate Intuitive's patent in 2019, stating that it was obvious in light of two previous patents by other inventors. Those patents were for a robotic surgery interface and a robotic stand that could hold numerous instruments, respectively.
Robotic surgery uses robotic arms to manipulate surgical instruments under the supervision of a human surgeon. The technique is designed to provide surgeons with more precise control than traditional surgery.
The global robotic surgery market is expected to produce $5.46 billion in 2020, according to a report by Research and Markets. Auris is seen as a serious competitor to industry leader Intuitive.
